These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10363157)

  • 1. [Control of tumor-related angiogenesis].
    Oikawa T
    Hum Cell; 1998 Dec; 11(4):201-6. PubMed ID: 10363157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant platelet factor 4: a therapeutic, anti-neoplastic chimera?
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2010 Jul; 36(5):558-69. PubMed ID: 20632253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiogenesis.
    Folkman J; Ingber D
    Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in the development of anti-tumor metastatic drugs].
    Kumagai H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):585-91. PubMed ID: 7536403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic effects of marine sponge derived compounds on cancer.
    Senthilkumar K; Venkatesan J; Manivasagan P; Kim SK
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):1097-108. PubMed ID: 24148290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparins and angiogenesis.
    Norrby K
    APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of tumor angiogenesis as a cancer treatment].
    Verheul HM; Bom JB; Hoekman K; Pinedo HM
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in cancer.
    Juczewska M; Chyczewski L
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():86-100. PubMed ID: 9337527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.
    Pluda JM
    Semin Oncol; 1997 Apr; 24(2):203-18. PubMed ID: 9129690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E; Honoré S; Braguer D
    Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
    Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
    Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of apoptosis and inhibition of AP-1 activity by TAC-101 (4-[3,5-bis(trimethylsilyl) benzamido] benzoic acid) may result in life prolonging effect in animals bearing metastasizing cancer.
    Shibata J; Murakami K; Aoyagi Y; Oie S; Hashimoto A; Suzuki K; Sano M; Wierzba TT; Yamada Y
    Anticancer Res; 2000; 20(5B):3583-90. PubMed ID: 11131666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer.
    Bertolini F; Marighetti P; Martin-Padura I; Mancuso P; Hu-Lowe DD; Shaked Y; D'Onofrio A
    Drug Discov Today; 2011 Dec; 16(23-24):1052-60. PubMed ID: 21875682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
    Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
    Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity.
    Shibata J; Murakami K; Wierzba K; Aoyagi Y; Hashimoto A; Sano M; Toko T; Yamada Y
    Anticancer Res; 2000; 20(5A):3169-76. PubMed ID: 11062739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis.
    Ledzewicz U; Schättler H
    J Theor Biol; 2008 May; 252(2):295-312. PubMed ID: 18371982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.